Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Childhood Cancers
- Sponsor
- Rutgers, The State University of New Jersey
- Enrollment
- 212
- Locations
- 5
- Primary Endpoint
- Beck Depression Inventory
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The investigators have developed a parent social-cognitive processing intervention (P-SCIP) to help decrease distress among parent caregivers of children undergoing hematopoietic stem cell transplant (HSCT). The investigators will evaluate the efficacy of P-SCIP in reducing short- and long-term distress and parenting stress among 300 parents of children undergoing HSCT. P-SCIP will be delivered during the child's inpatient HSCT hospitalization and is specifically designed to improve parent social (e.g., sharing concerns) and cognitive (e.g., acceptance) processing of the transplant experience. The intervention includes five in-person sessions that are accompanied by an interactive CD-ROM. The CD-ROM complements the materials in the in-person sessions and provides parents with the opportunity to enhance and deepen their cognitive and social processing of the HSCT experience. The intervention will be tested against best-practices psychosocial care (BPC) available in four enriched pediatric HSCT settings across the United States. P-SCIP will be provided to both Spanish- and English-speaking parents. Participants will complete measures of psychological distress, well-being, and social and cognitive processing at the time of HSCT, two, six and twelve months after HSCT. Research questions will address the effects of P-SCIP versus BPC on parent psychological adaptation and social and cognitive processing, as well as evaluate parent personal resources as well as child medical course variables that contribute to intervention response. The investigators will also examine barriers to participation in the intervention by comparing barriers to participation among parents who refuse participation in the trial and parents who accept.
Investigators
Eligibility Criteria
Inclusion Criteria
- •biological or foster parent of children under 19 years of age who are scheduled for HSCT within the next month
- •participant is the primary caregiver
- •participant must have phone service
- •caregiver speaks, reads, and writes English or Spanish (Spanish is for Childrens Hospital Los Angeles and Columbia University only)
Exclusion Criteria
- •pediatric patient has a diagnosis of medulloblastoma or other cancer of the brain
Outcomes
Primary Outcomes
Beck Depression Inventory
Time Frame: 7 years
Beck Anxiety Inventory
Time Frame: 7 years
Mental Health Inventory
Time Frame: 7 years
Impact of Events Scale-Revised
Time Frame: 7 years
Axis I Structured Clinical Interview for DSM-IV (SCID)
Time Frame: 7 years
Secondary Outcomes
- Fear Structure(7 years)
- Brief COPE(7 years)